Trastuzumab is the first of the monoclonal antibodies to be used in the treatment of those patients who have HER2-positive metastatic breast cancer. It is most effective when combined with ...

Future Oncol. 2008;4(1):125-131. © 2008 Future Medicine Ltd. No writing assistance was utilized in the production of this manuscript. Cite this: Trastuzumab as the ...